Geode Capital Management
DARE icon

Geode Capital Management’s Dare Bioscience DARE Stock Holding History

Geode Capital Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$324K Buy
177,839
+59,184
+50% +$101K ﹤0.01% 3747
2025
Q4 		$229K Sell
118,655
-4,718
-4% -$9.41K ﹤0.01% 3857
2025
Q3 		$259K Buy
123,373
+27,918
+29% +$62.9K ﹤0.01% 3842
2025
Q2 		$228K Sell
95,455
-450
-0.5% -$1.31K ﹤0.01% 3831
2025
Q1 		$277K Buy
95,905
+3,252
+4% +$10.1K ﹤0.01% 3745
2024
Q4 		$289K Buy
92,653
+3,593
+4% +$12.5K ﹤0.01% 3778
2024
Q3 		$289K Buy
89,060
+5,180
+6% +$17.7K ﹤0.01% 3779
2024
Q2 		$371K Buy
83,880
+1,438
+2% +$6.97K ﹤0.01% 3677
2024
Q1 		$485K Buy
82,442
+1,515
+2% +$7.42K ﹤0.01% 3629
2023
Q4 		$300K Buy
80,927
+12,762
+19% +$58.3K ﹤0.01% 3802
2023
Q3 		$378K Buy
68,165
+54
+0.1% +$444 ﹤0.01% 3711
2023
Q2 		$744K Hold
68,111
– – ﹤0.01% 3470
2023
Q1 		$850K Hold
68,111
– – ﹤0.01% 3416
2022
Q4 		$678K Sell
68,111
-158
-0.2% -$1.77K ﹤0.01% 3537
2022
Q3 		$819K Buy
68,269
+8,641
+14% +$119K ﹤0.01% 3494
2022
Q2 		$880K Buy
59,628
+1,417
+2% +$21.3K ﹤0.01% 3486
2022
Q1 		$1.04M Buy
58,211
+17,993
+45% +$340K ﹤0.01% 3601
2021
Q4 		$965K Sell
40,218
-7,006
-15% -$144K ﹤0.01% 3741
2021
Q3 		$946K Buy
47,224
+21,364
+83% +$421K ﹤0.01% 3712
2021
Q2 		$586K Buy
25,860
+4,256
+20% +$72.7K ﹤0.01% 3866
2021
Q1 		$438K Buy
21,604
+4,017
+23% +$98K ﹤0.01% 3856
2020
Q4 		$282K Buy
17,587
+10,235
+139% +$143K ﹤0.01% 3778
2020
Q3 		$88K Hold
7,352
– – ﹤0.01% 3927
2020
Q2 		$87K Hold
7,352
– – ﹤0.01% 3887
2020
Q1 		$74K Sell
7,352
-4,653
-39% -$62.6K ﹤0.01% 3846
2019
Q4 		$118K Hold
12,005
– – ﹤0.01% 3944
2019
Q3 		$110K Hold
12,005
– – ﹤0.01% 3927
2019
Q2 		$122K Buy
12,005
+3,216
+37% +$38.2K ﹤0.01% 3913
2019
Q1 		$147K Hold
8,789
– – ﹤0.01% 3811
2018
Q4 		$73K Buy
8,789
+3,931
+81% +$41.4K ﹤0.01% 3917
2018
Q3 		$56K Hold
4,858
– – ﹤0.01% 4018
2018
Q2 		$68K Buy
+4,858
New +$64.9K ﹤0.01% 3942
2017
Q3 		– Sell
-712
Closed -$37K – 4059
2017
Q2 		$37K Sell
712
-34
-5% -$1.98K ﹤0.01% 3994
2017
Q1 		$72K Buy
746
+5
+0.7% +$722 ﹤0.01% 3882
2016
Q4 		$62K Buy
741
+3
+0.4% +$286 ﹤0.01% 3881
2016
Q3 		$90K Buy
738
+1
+0.1% +$224 ﹤0.01% 3826
2016
Q2 		$187K Hold
737
– – ﹤0.01% 3615
2016
Q1 		$239 Sell
737
-1
-0.1% -$282 ﹤0.01% 3574
2015
Q4 		$247K Buy
738
+2
+0.3% +$830 ﹤0.01% 3599
2015
Q3 		$323K Buy
736
+1
+0.1% +$503 ﹤0.01% 3449
2015
Q2 		$405K Buy
735
+409
+125% +$281K ﹤0.01% 3294
2015
Q1 		$352K Buy
326
+118
+57% +$114K ﹤0.01% 3344
2014
Q4 		$155K Buy
208
+51
+32% +$31.8K ﹤0.01% 3675
2014
Q3 		$79K Buy
+157
New +$83.7K ﹤0.01% 3787

Other funds holding DARE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management's DARE Position: Q1 2026 in Review

Geode Capital Management increased its Dare Bioscience (DARE) stake by 50% in Q1 2026, buying an estimated $101K and bringing the position to 177,839 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #3747.

Geode Capital Management first reported a position in DARE in Q3 2014 and has held it in 44 quarters since. The position peaked at $1.04M in Q1 2022. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • Geode Capital Management held 177,839 shares of Dare Bioscience worth $324K as of Q1 2026.
  • Geode Capital Management bought 59,184 Dare Bioscience shares in Q1 2026, an estimated $101K.
  • Dare Bioscience made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3747 holding.
  • Geode Capital Management first reported a position in Dare Bioscience in Q3 2014 and has held it in 44 quarters since.
  • Geode Capital Management's Dare Bioscience position peaked at $1.04M in Q1 2022.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.